
Clinical Trials - November 1, 2017
Prometic receives clearance from the Swedish Medical Products Agency
Prometic Life Sciences has announced that it has received Swedish Medical Products Agency (MPA) Clinical Trial Application (CTA) approval to commence a clinical trial of its plasminogen therapy in patients suffering from chronic tympanic membrane perforation (chronic TMP). The clinical trial is a dose escalation, randomized, placebo-controlled study designed to investigate the safety, feasibility and […]